our projects

The Glioblastoma BioBank Project

The Glioblastoma Biobank Project, formally known as Key LARGO (Key Longitudinal Associations with Risk and Glioblastoma Outcomes), is now live and open for enrollment!

 

 

About The Glioblastoma BioBank Project

This groundbreaking study, conducted at the Preston Robert Tisch Brain Tumor Center at Duke, is generously funded by the Glioblastoma Research Organization and StacheStrong, two leading nonprofits dedicated to advancing brain cancer research.

This global study is designed to better understand glioblastoma, one of the most aggressive forms of brain cancer. By collecting biological samples and detailed surveys from patients with GBM, the study explores how genetic, immune, and lifestyle factors influence outcomes and risk.

Why this matters: The research will uncover insights to improve survival rates, enhance quality of life, and advance equitable care for patients everywhere.

Anyone in the world can join us in this effort! Whether you’re a GBM patient, a caregiver, or someone with a first degree relation to glioblastoma - your participation can make a difference. Together, we’re paving the way for personalized solutions, empowering patients and caregivers, and fostering breakthroughs in glioblastoma research.

To watch the video talking about the project and demonstrating the blood test kit click below.

Featured
Project Rocket
Project Rocket

Marking the GBMRO'S first funded research project of 2025, Project Rocket, formally known as Characterizing Glioblastoma Progression, Pseudoprogression, and Radiation Necrosis with Bedside Ultrasound Using Sonolucent Cranial Implants, led by Dr. Randy S. D’Amico, aims to identify key ultrasound markers that reveal whether the tumor is growing, healing, or experiencing other changes.

Learn More

Project DeLaRosa
Project DeLaRosa

The Glioblastoma Research Organization (GBMRO) announces its largest donation to date, $80,000, to fund Project DeLaRosa in partnership with Children's National Hospital.

learn more

Project Every Day Counts
Project Every Day Counts

Project Every Day Counts was launched with a $50,000 donation in collaboration with Gray for Glioblastoma Society to Children’s Hospital Los Angeles. The project honors Josh Wexler and the Wexler Family and their dedication to furthering GBM research.

learn more

Project Garcia
Project Garcia

Project Garcia marks GBMRO’s fourth fully funded Glioblastoma research project and the first in collaboration with Sylvester Comprehensive Cancer Center in Miami, Florida. The project includes novel research that uniquely applies a multiparametric intraoperative strategy to guide tumor resection and identify infiltrating tumor cells responsible for tumor recurrence.

learn more

Project Nate Roston
Project Nate Roston

The median age for diagnosis of Glioblastoma is 65, with patient prognosis known to decline with increased age. Christopher Hine, Ph.D., a researcher in the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute, has a theory that could explain why.

learn more

Project Rush
Project Rush

The Glioblastoma Research Organization's Project Rush is in collaboration with Lenox Hill Hospital’s Department of Neurosurgery’s Brain Tumor Center in New York City. Project Rush was inspired by the passing of Neil Peart a Canadian-American musician, best known as the drummer and lyricist of the rock band, Rush.

learn more

The Lee Project
The Lee Project

Funded by the Glioblastoma Research Organization, the laboratory of Dr. Steven Millward at the University of Texas MD Anderson Cancer Center has launched The Lee Project, which focuses on the directed evolution of vectors for treating GBM.

learn more

Project Liam
Project Liam

Brain tumors are the leading cause of cancer-related death in children. Of all the pediatric brain tumors, high-grade gliomas (HGG) remain the greatest challenge, with few treatment options available and a five-year survival rate of only 10-30 percent. A potential alternative to conventional treatments is to utilize a patient’s own immune system to attack tumor cells—immunotherapy.

learn more

Our other Projects